1. Home
  2. MGTX vs PGY Comparison

MGTX vs PGY Comparison

Compare MGTX & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$12.11

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$15.87

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGTX
PGY
Founded
2015
2016
Country
United States
United States
Employees
N/A
511
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
909.1M
1.1B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
MGTX
PGY
Price
$12.11
$15.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$24.57
$34.50
AVG Volume (30 Days)
780.8K
3.8M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
33.02
N/A
EPS
N/A
N/A
Revenue
$81,391,000.00
N/A
Revenue This Year
$141.38
$14.27
Revenue Next Year
N/A
$14.39
P/E Ratio
N/A
$13.54
Revenue Growth
144.57
N/A
52 Week Low
$6.31
$10.40
52 Week High
$12.28
$44.99

Technical Indicators

Market Signals
Indicator
MGTX
PGY
Relative Strength Index (RSI) 69.21 56.78
Support Level $7.10 $10.78
Resistance Level $11.85 $16.42
Average True Range (ATR) 0.63 1.13
MACD 0.22 -0.01
Stochastic Oscillator 83.63 63.85

Price Performance

Historical Comparison
MGTX
PGY

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

Share on Social Networks: